The Recall Desk
ModerateFDA (Devices)·Z-3093-2026·Announced 2026-09-09

Fresenius Citrasate Liquid Acid Concentrate Recalled for Discoloration

Fresenius Medical Care is recalling Citrasate Liquid Acid Concentrate for Bicarbonate Hemodialysis due to complaints of blue-green discoloration.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is classified as FDA Class II, and the hazard is a cosmetic defect (discoloration) with no reported injuries or illnesses, fitting the criteria for a moderate severity score.

Plain-English summary

Fresenius Medical Care Renal Therapies Group, LLC is recalling Citrasate, Liquid Acid Concentrate for Bicarbonate Hemodialysis. The recall involves specific product numbers and lot numbers, including 08-2251-CA, 08-3251-CA, and 13-2251-CA.

The recall was initiated due to complaints of blue-green discoloration in the product. The affected units were distributed worldwide, including the United States and Mexico.

Healthcare facilities and consumers should stop using the affected lots and contact the manufacturer for further instructions.

The recalled product

Product
Citrasate, Liquid Acid Concentrate for Bicarbonate Hemodialysis: Product Numbers: 08-2251-CA, 08-3251-CA, 13-2251-CA; Liquid Acid Concentrate for Bicarbonate Hemodialysis

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (10)

  • 1) 08-2251-CA
  • UDI/DI 00840861101344
  • Lot Numbers: 26BXAC038
  • 2) 08-3251-CA
  • UDI/DI 00840861101351
  • Lot Numbers: 26BXAC039
  • 3) 13-2251-CA
  • UDI/DI 00840861101375
  • Lot Numbers: 26BXAC040
  • 26BXAC041.

Distribution

Distributed nationwide across the United States.

Same manufacturer · Fresenius Medical Care Renal Therapies Group, LLC

See all →